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Abstract
Background: The product of a novel cytokine-responsive gene discovered by differential display analysis
in our earlier studies on HepG2 cells was identified as mimitin – a small mitochondrial protein. Since
proinflammatory cytokines are known to affect components of the respiratory chain in mitochondria, and
mimitin was reported as a possible chaperone for assembly of mitochondrial complex I, we looked for the
effects of modulation of mimitin expression and for mimitin-binding partners.
Results: By blocking mimitin expression in HepG2 cells by siRNA we found that mimitin has no direct
influence on caspase 3/7 activities implicated in apoptosis. However, when apoptosis was induced by TNF
and cycloheximide, and mimitin expression blocked, the activities of these caspases were significantly
increased. This was accompanied by a slight decrease in proliferation of HepG2 cells. Our observations
suggest that mimitin may be involved in the control of apoptosis indirectly, through another protein, or
proteins. Using the yeast two-hybrid system and coimmunoprecipitation we found MAP1S among proteins
interacting with mimitin. MAP1S is a recently identified member of the microtubule-associated protein
family and has been shown to interact with NADH dehydrogenase I and cytochrome oxidase I. Moreover,
it was implicated in the process of mitochondrial aggregation and nuclear genome destruction. The
expression of mimitin is stimulated more than 1.6-fold by IL-1 and by IL-6, with the maximum level of
mimitin observed after 18–24 h exposure to these cytokines. We also found that the cytokine-induced
signal leading to stimulation of mimitin synthesis utilizes the MAP kinase pathway.
Conclusion:  Mimitin is a mitochondrial protein upregulated by proinflammatory cytokines at the
transcriptional and protein levels, with MAP kinases involved in IL-1-dependent induction. Mimitin
interacts with a microtubular protein (MAP1S), and some changes of mimitin gene expression modulate
activity of apoptotic caspases 3/7, suggesting that this protein may indirectly participate in apoptosis.
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Background
Tissue injury initiates complex inflammatory reactions
known as the acute phase response in which the principal
role is played by cytokines such as IL-1, TNF and IL-6. In
the liver these cytokines, particularly IL-6, drastically alter
the pattern of synthesized cellular and secreted proteins
[1,2]. Established cell lines of liver origin (e.g. HepG2
cells) represent a useful model for studying the regulation
of liver-specific gene expression. In a recently published
report [3] we employed differential display analysis to
monitor changes in the transcript profile of HepG2 cells
stimulated with IL-1, IL-6 and a mixture of both cytokines.
We identified over 80 genes responding to these cytokines
and encoding several proteins of known structure and
function. Additionally, we found some 40 cytokine-sensi-
tive transcripts coding for unknown or poorly character-
ized proteins. One of those genes coding for a 20 kDa
polypeptide was selected for further detailed characteriza-
tion.
During those studies we concluded that the analyzed
sequence corresponds to a gene described recently by Tsu-
neoka and co-workers [4] and induced in various human
tumor cells overexpressing c-Myc. The protein product of
this gene was named mimitin (Myc-induced mitochondrial
protein) since it was localized in mitochondria and con-
tained an ATP/GTP binding motif as well as a domain
called Complex1_17_2 kDa. These data strongly sug-
gested that mimitin may be involved in ATP metabolism
in mitochondria. In agreement with the postulated regu-
latory role of c-Myc in the expression of mimitin, a spe-
cific c-Myc binding site was identified in the promoter
region of mimitin gene. Further analyses carried out by
independent research groups [5,6] suggest that mimitin
plays the role of a molecular chaperone for the assembly
of mitochondrial complex I.
In the present paper, we report that the mimitin gene is
activated by the proinflammatory cytokines IL-1 and IL-6,
and we describe the temporal pattern of cytokine response
as well as identification of the signalling pathways
involved. We also compare the abundance of mimitin
transcript in different human tissues and analyze the sig-
nificance of mimitin for cell proliferation and cell
response to apoptotic signals.
Results
Cytokine-induced changes in the expression of mimitin 
gene
The mimitin transcript was initially detected by us [3] by
differential display analysis in HepG2 cells stimulated
with IL-1. To study the importance of proinflammatory
cytokines in mimitin gene expression HepG2 cells were
stimulated with IL-1, IL-6 or a mixture of both cytokines.
Changes in gene expression were evaluated at the tran-
script and protein levels (Fig. 1A and 1B). In Northern
blot analysis the densitometric values of bands corre-
sponding to mimitin transcript were measured for control
(unstimulated) cells and cells stimulated with IL-1 or IL-
6. In case of cytokine mixture, cells were prestimulated
with IL-1 and then stimulated with IL-6 to simulate the
physiological cascade of events. In all cases exposure to
cytokines led to an increase in mimitin mRNA abun-
dance. The highest transcript level observed after 12 h of
stimulation with IL-1 or IL-6 exceeded control levels by
1.9 and 1.5 times, respectively (Fig. 1A). In the case of the
two cytokines combined we observed 1.6-fold up-regula-
tion of mimitin mRNA after 27/24 h of cytokine exposure
(Fig. 1A).
To evaluate changes in protein level polyclonal antisera of
high titre were raised in rabbits against recombinant mim-
itin. The antibodies generated specifically recognized
recombinant as well as endogenous mimitin in Western
blot analysis. For accurate serial measurements ELISA tests
were carried out and the obtained results compared with
the Northern blotting data. As shown in Fig. 1B, a 2-fold
increase of mimitin level occurs after 12 h of stimulation
with IL-1, or after 18 h of stimulation with IL-6. A sus-
tained increased level of mimitin is still seen after 24 h
stimulation with IL-1 alone or with the IL-1/IL-6 mixture.
The obtained results indicate that stimulation of HepG2
cells with the mixture of cytokines leads to a more pro-
longed expression of the mimitin gene than stimulation
with a single cytokine, the effect being manifested at the
levels of both mRNA and protein.
Induction of mimitin by IL-1 involves MAP kinases but not 
the NFκB pathway
To investigate the role of NFκB signalling pathway in acti-
vation of mimitin gene by IL-1 we used a cell line stably
transfected with retroviral vector pCFG5-IEG2 encoding a
non-degradable mutant of the inhibitor of NFκB
(mIκBα). Cells stably transfected with the empty vector
served as a control. The control and mIκBα-expressing
cells were stimulated with IL-1 for 12 h. To monitor the
level of mimitin transcript Northern blot analysis was car-
ried out. As shown in Fig. 2A and 2B, the level of mimitin
transcript in HepG2 cells expressing mIκBα and stimu-
lated with IL-1 is the same as it is in case of IL-1 stimulated
control. Thus, the NFκB signalling pathway appears not to
be involved in the expression of IL-1-dependent activa-
tion of mimitin gene. It is known, however, that another
signalling pathway important in the expression of IL-1-
regulated genes involves MAP kinases. To check if this
pathway is engaged in mimitin regulation three potent,
selective, pharmacological inhibitors of MAPKs cascade
were used: U0126 for ERK, SP600125 for JNK, ZM336372
for p38 The specificity of each inhibitor was verified byBMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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Western blotting with antisera against phosphorylated
forms of individual kinases (Fig. 2D), and a lack of cyto-
toxic effects was confirmed by the MTT assay (data not
shown). As shown in Fig. 2C all these inhibitors abolished
the IL-1-induced elevation of mimitin mRNA level, con-
firming the involvement of MAP kinases in the stimula-
tion of mimitin gene expression by IL-1.
Expression of mimitin in human tissues
A commercial blot with mRNA isolated from a number of
normal human cells, organs and tissues was used to esti-
mate the pattern of mimitin expression at the mRNA level.
The probe corresponding to the whole coding sequence of
mimitin gene recognized a single transcript of approxi-
mately 640 nt. Among the tissues examined, the mimitin
mRNA level was the highest in the heart, with considera-
bly lesser amounts found in the liver, skeletal muscles and
kidney. Only traces were detected in the other tissues
investigated (Fig. 3).
Subcellular localization of mimitin
To determine the subcellular localization of mimitin the
Qproteome Kit for cell compartment fractionation was
used. Protein extracts were isolated from HepG2 cells
according to manufacturer's procedure, separated on
polyacrylamide gel and analyzed by Western blotting with
monoclonal or polyclonal antibodies specific for mimi-
tin. Commercial anti-laminin, anti-GAPDH and anti-pro-
hibitin polyclonal antibodies were used to detect markers
of typical subcellular fractions. The analysis revealed that
Mimitin gene expression in HepG2 cells stimulated with IL-1, IL-6 or with both cytokines Figure 1
Mimitin gene expression in HepG2 cells stimulated with IL-1, IL-6 or with both cytokines. Cells were stimulated 
with the cytokines and the mimitin transcript level was evaluated by Northern blotting (A). The data are presented relatively to 
the mimitin transcript level in unstimulated control cells harvested after 4, 12, and 24 h. A lower panel shows representative 
results from Northern blot hybridization and ethidium bromide-stained 28S rRNA. Changes in the mimitin protein level esti-
mated by ELISA were calculated relatively to unstimulated control cells (B). Vertical bars indicate the values of standard error 
of three independent experiments (*p < 0.05, **p < 0.02, ***p < 0.01).
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mimitin is co-localized with prohibitin in the membrane
fraction (Fig. 4A). This fraction consists of plasma and
organelle membranes (except for the nuclear envelope).
In order to determine the localization of mimitin in more
detail the procedure of Ndubuisi et al. was used to isolate
the mitochondrial fraction [7]. Analysis of this fraction
confirmed mitochondrial association of mimitin (Fig.
4B), in full agreement with the data of Tsuneoka et al. [4].
Identification of mimitin-binding proteins
The results of experiments described below suggested that
mimitin, being a mitochondrial protein, might participate
in various pathways of cellular metabolism and initiation
of apoptosis. This participation could be indirect, via a
partner protein. As the first step in the identification of
mimitim partners we used yeast two-hybrid screening and
the Matchmaker human foetal brain cDNA library. From
31 selected clones seven positive clones were isolated of
which four encoded microtubule associated protein 1S
(MAP1S), one encoded stathmin-like 2 protein and the
remaining two had no similarity to any cDNA in the NCBI
database. MAP1S protein was chosen for further analysis
because Liu and co-workers [8] showed that when MAP1S
protein accumulates in cells, it appears to be localized on
mitochondria and induces distinct perinuclear aggregates
of mitochondria. Moreover, it was shown that MAP1S
interacts with mitochondrial NADH dehydrogenase I and
cytochrome c oxidase I [9].
Signalling pathway engaged in IL-1-dependent activation of mimitin gene Figure 2
Signalling pathway engaged in IL-1-dependent activation of mimitin gene. A. Representative Northern blots: HepG2 
cells stably transfected with retroviral vector pCFG5-IEG2 encoding nondegradable mutant of IκBα, and cells with an empty 
vector (mock-control) were stimulated with IL-1 (12 h) and the level of mimitin transcript was measured. Results obtained for 
both types of cells were normalized to 18S rRNA level. B. The graph represents data calculated from three independent 
Northern blot experiments. Error bars indicate the values of standard deviation (**p < 0.02). C. HepG2 cells were pretreated 
with: 10 μM U0126, 10 μM SP600125, or 10 μM ZM336372 for 30 min and then stimulated with 15 ng/ml IL-1 for 12 h. The 
level of mRNA coding for mimitin was estimated in comparison to control (unstimulated cells) by real-time PCR. Error bars 
indicate standard deviation from three independent experiments (*p < 0.05, **p < 0.02). D. Western blot analysis confirming 
activity of inhibitors of MAPK kinases. HepG2 cells were pretreated for 30 min with inhibitors (as in Fig. 2C), stimulated with 
15 ng/ml IL-1 for 10 min and then cell lysates were analyzed by Western blotting with anti-P-Erk, anti-P-JNK and anti-P-p38 
antibodies. The blot was later stripped and reprobed with an α-tubulin antibody (bottom panel) to ensure equal loading.BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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We carried out a coimmunoprecipitation assay to investi-
gate whether mimitin associates with MAP1S in vivo. Vec-
tors encoding Myc-tagged MAP1S with its transactivator
and mimitin were transfected separately or together into
HepG2 cells. Protein lysates were loaded on a column
with antibodies for c-Myc and specific eluates were then
subjected to Western blotting with either anti-mimitin or
anti-Myc antibodies. As shown in Fig. 5, signals for
MAP1S are visible with c-Myc antibodies in eluates pre-
pared from HepG2 cells overexpressing only MAP1S-c-
Myc or MAP1S-c-Myc with mimitin. A signal for mimitin
is seen only for the eluate from HepG2 cells overexpress-
ing both proteins (Fig. 5). This indicates that mimitin
does in fact form a complex with MAP1S in vivo which
confirms the yeast two-hybrid data.
Effects of mimitin level on cell viability
To investigate the role of mimitin on cell viability we ana-
lysed the influence of changes of mimitin gene expression
on HepG2 cell proliferation and susceptibility to apopto-
sis. For effective knockdown of mimitin gene, HepG2 cells
were transfected with two different siRNAs (A and B) in
two concentrations (50 and 100 nM). As a positive con-
trol siRNA specific for GAPDH was used, whereas a siRNA
with a scrambled sequence served as a negative control.
Additional control (blank) was obtained by treatment of
cells with the transfection reagent siPORT™ NeoFX™ alone.
The efficiency of knockdown was evaluated 72 h post
transfection by measuring mimitin level by Western blot-
ting. We found that cell treatment with mimitin-A-specific
siRNA led to an almost complete disappearance of this
protein from the cells, while siRNA-mimitin-B only
slightly reduced mimitin level (data not shown). The
silencing effect was specific, since there was no reduction
of mimitin level in the cells treated with GAPDH siRNA,
negative control siRNA or transfection reagent alone.
Based on preliminary results, mimitin-A siRNA at 50 nM
was selected for further knockdown experiments.
The mimitin gene was silenced in HepG2 cells using the
established parameters and then caspase 3 and 7 activities
were assayed, since they are known to be involved in pro-
grammed cell death [10-12]. The knockdown of mimitin
gene had no effect on caspase 3 and 7 activities. This indi-
cated that the level of mimitin has no direct influence on
the basic activities of these caspases; however, it could still
modulate them once they had been induced by a pro-apop-
totic signal. Indeed, when we first induced apoptosis by
treating the cells with TNF/CHX and then determined these
caspases we found a striking effect of mimitin. HepG2 cells
treated with siRNA specific for mimitin (mimitin-A)
showed approximately 15 fold increase in the activity of
caspases in comparison to negative control (Fig. 6A). Mim-
itin silencing was confirmed by Western blot analysis (Fig.
6B). However, treatment of cells with a GAPDH-specific
siRNA had an even stronger effect on caspase activities (38-
fold increase), although the protein level of GAPDH was
only slightly reduced (Fig. 6B). The effects of both transfec-
tions show statistically significant differences in compari-
son to the negative control, with p < 0.02 for the mimitin-
Abundance of mimitin transcripts in human tissues Figure 3
Abundance of mimitin transcripts in human tissues. 32P-labelled molecular probe for mimitin or beta actin transcript 
(control) was used for hyridization with commercial membrane loaded with 2 μg of mRNA isolated from 12 different human 
tissues: 1. brain, 2. heart, 3. skeletal muscles, 4. colon, 5. thymus, 6. spleen, 7. kidney, 8. liver, 9. small intestine, 10. placenta, 11. 
lung, 12. peripheral blood leukocytes. For mimitin gene, a single trasncript of 640 nt is detected; for beta actin a single 2.0 kb 
band is present in all lanes. A 1.8 kb actin isoform is visible in the heart and skeletal muscle lanes.BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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specific siRNA and p < 0.05 for GAPDH specific siRNA. The
result obtained in HepG2 cells with the GAPDH-specific
siRNA is not surprising because some reports indicate that
silencing of the gene coding for GAPDH in tumour cells
decreases the rate of glycolysis, inhibits cell proliferation
and eventually leads to apoptosis [13,14].
We conclude that although mimitin has no direct influ-
ence on the basal activities of caspases 3/7, changes of its
expression may profoundly affect these enzymes in the
course of TNF/CHX-induced apoptosis.
The importance of mimitin in regulation of caspase 3/7
activities during apoptosis was confirmed by overexpres-
sion of mimitin in HepG2 cells treated with a mixture of
TNF and CHX. HepG2 cells transfected with the pcDNA-
mimitin vector and treated with TNF/CHX showed a 2-
fold decrease of caspase 3/7 activity compared to control
(Fig. 7). This result is in a full agreement with the data
obtained after knockdown of mimitin gene expression.
Silencing of mimitin gene in cells with induced apoptosis
increases caspase 3/7 activities, whereas its overexpression
gives an opposite effect.
To exclude the possibility that the observed changes in cell
viability are not caused by cytotoxic effects of TNF and
CHX, the release of LDH from the cells was measured. It
was found that neither transfection of cells with different
siRNAs, nor TNF/CHX treatment, lead to increased LDH
release which is regarded as an indicator of cell death via
necrosis (data not shown). Then the effect of the mimitin
gene silencing on cell proliferation was determined by
BrdU-incorporation in HepG2 cells transfected with
siRNA targeting mimitin. As shown in Fig. 8, silencing
with mimitin-A siRNA resulted in a small but significant
(p < 0.05) decrease of BrdU-incorporation compared to
control cells. Thus, we conclude that a reduced cellular
level of mimitin slightly decreases the rate of DNA replica-
tion and cell proliferation. On the other hand, overexpres-
sion of mimitin seemed to have no effect on HepG2
proliferation (data not shown).
Discussion
Proinflammatory cytokines modulate expression of sev-
eral mitochondrial proteins participating in ATP genera-
tion, as it was shown in our previous studies [3,15].
Cytokines such as IL-1 and IL-6 are known to influence
energy metabolism and mitochondrial function [16], sig-
nificantly inhibiting ATP production and utilization in a
time- and dose-dependent manner, as it was shown in pri-
mary cultures of rat hepatocytes [17,18]. In our experi-
ments we observed an increase in the levels of mimitin
transcript and mimitin protein after 12 and 18 h of
HepG2 cells exposure to IL-1 and IL-6. These cytokines
also stimulated expression of the luciferase reporter gene
under control of the mimitin gene promoter (data not
shown). Therefore, it can be concluded that both
cytokines regulate mimitin gene expression at the tran-
scriptional level.
It is puzzling why the proinflammatory cytokines activate
expression of a gene coding for a mitochondrial protein.
In an attempt of answering this question we looked for
proteins interacting with mimitin. Using yeast two-hybrid
system and co-immunoprecipitation we found that one of
the proteins interacting with mimitin is MAP1S. This is a
recently described member of the microtubule-associated
protein 1 family, expressed in a wide range of tissues and
synthesized as a precursor protein that is cleaved into
heavy and light chains in a tissue-specific manner [19].
Liu and co-workers [9] showed that MAP1S is complexed
with mitochondrial NADH dehydrogenase I and cyto-
chrome c oxidase I resulting in "mitochondrial aggrega-
tion and genome destruction" [8]. The results of Liu and
co-workers suggest that MAP1S mediates communication
between the microtubular cytoskeleton and mitochon-
dria, especially in control of cell death [8].
Taking into consideration that mimitin is a mitochondrial
protein and that it probably functions as a molecular chaper-
one essential for the efficient assembly of complex I [5], we
expected that this protein could be important for cell viabil-
Subcellular localization of mimitin Figure 4
Subcellular localization of mimitin. Subcellular fractiona-
tion of HepG2 cells was done with Qproteome Kit (A) and 
the obtained cytosolic (lane 1), membrane (lane 2), nuclear 
(lane 3) and cytoskeletal proteins (lane 4) were checked for 
the presence of appropriate markers with monospecific anti-
bodies. Western blotting showed the presence of mimitin 
exclusively in the membrane fraction. In additional experi-
ments cytosolic (lane 5), mitochondrial (lane 6), microsomal 
(lane 7) and crude nuclear fraction containing unlysed cells 
(lane 8), were isolated (see Materials and Methods). This result 
confirmed the presence of mimitin solely in mitochondria.BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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ity. To investigate this hypothesis we studied the effect of
either inhibition or overexpression of mimitin on cell prolif-
eration, and cell survival. Blocking the expression of mimitin
in HepG2 cells by siRNA demonstrated that mimitin itself
has no direct influence on caspase 3/7 activities. However,
when apoptosis was induced with TNF and CHX the activity
of caspases was significantly increased by silencing mimitin
expression. Conversely, overexpression of mimitin in cells
induced to undergo apoptosis reduced the activity of these
caspases. Moreover, inhibition of mimitin gene slightly
decreased the proliferation rate of HepG2 cells, while mimi-
tin overexpression apparently had no effect.
Treatment of HepG2 cells with TNF/CHX initiates the
extrinsic apoptotic pathway and strongly stimulates effec-
tor caspases [20,21]. Since overexpression of mimitin
leads to a significant decrease in the activites of caspases
3/7 it is possible that potential antiapoptotic properties of
mimitin become apparent after interaction with some
pro-apoptotic proteins, such as the microtubular protein
– MAP1S. Further studies are required to elucidate the sig-
nificance of these interactions and to establish the exact
position of mimitin in cell death-related processes.
Conclusion
We confirmed that mimitin is a mitochondrial protein
and showed that it is regulated by proinflammatory
cytokines with a highest basal expression in the heart.
MAPK kinases, but not the NFκB-related pathway, were
shown to play a pivotal role in IL-1- dependent regula-
tion of mimitin gene. Mimitin was found to interact with
the microtubular protein MAP1S and modulation of
mimitin gene expression affected the activities of cas-
pases 3 and 7 but only in the cells stimulated to develop
apoptosis.
Methods
Cell culture and stimulation with IL-1 and IL-6
HepG2 cells (ATCC) were cultured at 37°C and 5% CO2
in Dulbecco Modified Eagle Medium (DMEM) with 1000
mg/L D-glucose (Sigma-Aldrich), supplemented with
10% foetal bovine serum (Gibco/BRL). Cells were grown
to approximately 80% confluence. Fifteen hours before
cytokine treatment they were washed twice in PBS and
placed in DMEM containing 0.5% FBS. Then the cells
were stimulated with human recombinant IL-1 (BioMol)
at the final concentration of 15 ng/ml, or with human
recombinant IL-6 (MP) at the final concentration of 25
ng/ml, or with a mixture of both. In the case of experiment
with IL-1 or IL-6 applied separately, cells were stimulated
for 4, 12, and 24 h. When both cytokines were used, cells
were prestimulated for 3 h with IL-1 and then stimulated
with IL-6 for the time indicated. The concentration of
both cytokines was optimized experimentally. The
responsiveness of HepG2 cells to these cytokines was eval-
uated in each series of experiments by comparing changes
in the levels of mRNA coding for known acute phase pro-
teins [3]. Non-stimulated cells harvested after 4, 12, and
24 h of the experiment served as controls.
Generation of genetic constructs and transfection 
procedure
The insert for pcDNA3mim and pQE31mim vector, con-
taining complete coding region of mimitin gene, was gen-
erated by PCR in two steps. The first round of PCR was
carried out with forward primer: tgctggcagcgctggaaac and
Coimmunoprecipitation of mimitin with MAP1S Figure 5
Coimmunoprecipitation of mimitin with MAP1S. In HepG2 cells MAP1S with c-Myc tag and mimitin genes were over-
expressed. The coimmunoprecipitation analysis was performed with ProFoundTM c-Myc Tag IP/Co-IP Kit. Proteins present in 
cells extracts and eluates were detected in Western blot with antibodies specific for Mimitin and specific for Myc tag in case of 
MAP1S.BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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reverse: agtcacatccatatacatgaaaag. The following nested
primers: forward: cggcatgggttggtctc with restriction site for
KpnI and reverse: atgcattcattgattgtcgc with restriction site
for SmaI/XmaI were used to obtain a region of 520 nucle-
otides, corresponding to positions -4 to 516 relative to the
mimitin ATG start codon. After digestion of the PCR prod-
uct with KpnI/SmaI and of the pcDNA3 vector with KpnI/
EcoRV ligation was carried out. For the recombinant pro-
tein purification the same procedure was used but the for-
ward primer had SacI restriction site. Both constructs were
sequenced before the transfection/transformation experi-
ment. Plasmids overerexpressing MAP1S were kindly pro-
vided by Prof. Friedrich Propst [19]. Expression of MAP1S
was under the control of tet-responsive promoter. For
overexpression of MAP1S in HepG2 cells co-tranfection of
UHD15-1 (containing tTA transactivator) and pUHD10-3
(containing full length MAP1S) was carried out. To over-
express mimitin or MAP1S, HepG2 cells were transfected
with the following genetic constructs: pcDNA3 empty vec-
tor (control), pcDNA3mim, pUHD15-1 or pUHD10-3
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer's procedure.
To estimate the efficiency of transfection in different sam-
ples we performed RT-PCR using primers specific for a
transcript coding for aminoglycoside phosphotransferase
(neomycin resistance gene; coded by pcDNA3) and EF2 as
a reference gene (NeoF: tgctcctgccgagaaagtat and NeoR:
aatatcacgggtagccaacg; EF2 11: gacatcaccaagggtgtgtgcag and
EF2 22: gcggtcagcacaatggaata).
Effect of mimitin gene silencing on caspase 3/7 activities Figure 6
Effect of mimitin gene silencing on caspase 3/7 activi-
ties. HepG2 cells were transfected with mimitin-siRNA, 
GAPDH-siRNA, negative control siRNA, or transfection rea-
gent (siPORT NeoFX) (blank). Apoptosis was induced 72 h 
post transfection by treatment of cells with TNF/CHX for 5 
h. Caspase 3/7 activity was measured using Caspase-GloTM3/
7 assay kit. A. Changes in caspase activity in cells with TNF/
CHX-induced apoptosis were compared to cells treated with 
TNF/CHX and transfected with a negative control siRNA 
(assumed as equal 1). In each case the value of caspase 3/7 
activity after TNF/CHX treatment was divided by the value 
of basal activity of non-stimulated cells. Values represent the 
mean of three independent experiments with error bars 
showing standard error (*p < 0.05). B. Representative West-
ern blot analysis with 20 μg protein from caspase activity 
assay using anti-GAPDH and anti-Mimitin antibodies. Samples 
marked (+) were stimulated with TNF/CHX while samples 
marked (-) were not stimulated.
Overexpression of mimitin decreases caspase 3/7 activities Figure 7
Overexpression of mimitin decreases caspase 3/7 
activities. HepG2 cells were transfected either with 
pcDNA3 empty vector, or pcDNA3mim and then not-
treated (control) or treated with TNF/CHX. Caspase activity 
was determined using Caspase-GloTM3/7 reagent. A. Graph 
presents changes in the relative changes in caspase 3/7 activ-
ity. In each case the value of caspase 3/7 activity after TNF/
CHX treatment was divided by the value of basal activity of 
nonstimulated cells. Caspase activity in cells overexpressing 
mimitin was compared to cells transfected with an empty 
vector pcDNA3 (assumed as equal 1). The values represent 
the mean of 3 independent experiments ± SD with *p < 0.05. 
B. Western blot confirming overexpression of mimitin in 
cells transfected with pcDNA3mim. The blot was later 
stripped and reprobed with an α-tubulin antibody (lower 
panel) to ensure equal loading. RT-PCR results show tran-
script level for neomycin resistance gene (exogenous gene in 
pcDNA3) as a control of transfection efficiency and tran-
script level for elongation factor 2 (endogenous gene) as a 
control of RNA amount in tested samples.BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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Northern blot analysis
In order to analyse tissue distribution of the mimitin tran-
script a commercial blot filter was used (Clontech). The
membrane had been loaded with 2 μg of mRNA isolated
from the following human tissues: brain, heart, skeletal
muscles, colon, thymus, spleen, kidney, liver, small intes-
tine, placenta, lung and peripheral blood leukocytes. Pre-
hybridization and hybridization were carried out at 65°C
in 1% SDS, 1 M NaCl, 10% dextran sulfate solution.
Thirty nanograms of the probe was labelled with [α-
32P]dCTP using a random primer labelling kit (Promega).
After washing (20 min at room temperature in 2 × SSC, 20
min at 65°C in 2 × SSC and then twice for 20 min. at 65°C
in 1 × SSC/1% SDS) the RNA blot was read using a Molec-
ular Imager FX and analysed with Quantity One (Biorad).
The blot was later stripped and reprobed with a β-actin
probe provided with the kit to check for equal loading.
In the experiment where the changes in mimitin transcript
level were studied total RNA was isolated from control
(unstimulated) cells and from cells after IL-1 and IL-6
treatment. The guanidinum/phenol extraction procedure
was used. Ten micrograms of total RNA was separated in
1% agarose-formaldehyde gel and blotted onto a nitrocel-
lulose membrane. Prehybridization and hybridization
were carried out as above. Quantitative analysis of the
transcript was based on densitometric readings from
Quantity One software. The intensity of each analysed
band was divided by the intensity of the 28S rRNA band
and the final results were calculated as the multiple of
suitable control. The reported values represent the mean
of three independent experiments.
Generation of mimitin-specific monoclonal and polyclonal 
antibodies
E. coli BL21 cells were transformed with pQE-31 vector
containing the entire coding sequence of mimitin. Recom-
binant protein was purified from bacterial culture using
BD Talon Metal Affinity Resins with cobalt ions (BD Bio-
sciences) and used in immunization of New Zealand
White rabbit (3 times 300 μg of antigen). Antibodies were
purified from rabbit sera by protein A-Sepharose chroma-
tography and then checked for specificity. The antibodies
were analyzed with protein extracts from HepG2 cells and
with recombinant mimitin by Western blotting. There was
no cross-reactivity and only specific product of the
expected size was observed on the membrane. An addi-
tional proof of the quality and specificity of the obtained
antibodies is the observed reduction of the signal in the
Western blot after the cells were transfected with siRNA
specific for mimitin.
For generation of a monoclonal antibody Balb/c mice
were immunized several times with recombinant mimitin
according to a standard protocol [22]. The specific IgG
titre exceeded 1:105. Splenocytes were fused with Sp2/0
myeloma cells (HPRT-/-) using polyethylene glycol
(Sigma-Aldrich) and the mixture of cells was cultured for
two weeks in HAT selection medium enriched with 10%
FCS and hybridoma growth supplement (Sigma-Aldrich).
The clones were analyzed for the synthesis of anti-mimitin
Ab in direct ELISA on microplates covered with recom-
binant mimitin (2 μg/ml). The clone 1F5D8 obtained
after a two-step subcloning procedure performed by serial
dilution was chosen for further work. Undiluted culture
medium of this clone (DMEM + 10%FCS) was used as a
source of the detecting antibody in indirect ELISA.
Cell lysate preparation and Western blot analysis
Whole cell protein extracts were obtained by washing cells
twice with ice-cold PBS and harvested in 1 ml of PBS con-
taining 10% (v/v) glycerol and EDTA (5 mM). After centrif-
ugation (1000 g, 10 min, 4°C), cell pellets were suspended
in 50 μl of lysis buffer (100 mM Tris-HCl pH 7.5; 1% Tri-
Effect of mimitin gene silencing on proliferation of HepG2  cells Figure 8
Effect of mimitin gene silencing on proliferation of 
HepG2 cells. Cells were transfected with silencing RNA 
specific for mimitin (50 nM), or for GAPDH (100 nM, posi-
tive control), or unspecific siRNA (negative control, 50 nM) 
or were treated with transfection reagent siPORT NeoFX 
alone (blank). At 72 h post transfection cells were incubated 
with BrdU (5 μM) for 3 h and incorporation was determined 
with Cell Proliferation ELISA. A. Cell proliferation is shown 
relative to the non-sepcific siRNA (control). Values were cal-
culated from absorbance readings at 450 nm and represent 
the mean of three independent experiments with standard 
deviation (*p < 0.05, **p < 0.02 compared to control). B. 
Representative Western blot analysis with 20 μg protein 
from simultaneously seeded 12-well plates using anti-
GAPDH or anti-mimitin antibodies.
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ton-X100 and protease inhibitor cocktail (Roche)). Protein
concentration of each sample was determined using the
bicinchoninic acid assay (BCA, Sigma-Aldrich). Ten micro-
grams of protein extract was loaded onto 10% polyacryla-
mide gel and separated by SDS/PAGE in Tris-tricine buffer
[23]. After transfer to nitrocellulose membrane blots were
blocked with 2% BSA in TBS-N buffer (20 mM Tris pH 8.0,
150 mM NaCl, 0.05% Nonidet P-40) overnight at 4°C and
then incubated with primary antibodies for 2 h at room
temperature. Polyclonal antibodies against mimitin, gener-
ated as described above, were used at 3 μg/ml. Secondary
HRP-conjugated anti-rabbit IgG was used at 1:80 000 dilu-
tion (Sigma-Aldrich). Both primary and secondary anti-
bodies were diluted with TBS-N containing 2% BSA. TBS-N
was used for washing the membranes before, between and
after incubation with antibodies. Immunoreactive bands
were detected by an enhanced chemiluminescence system
(SuperSignal West Pico Chemiluminescent Substrate,
Pierce) and visualized on medical x-ray film.
Identification of signalling pathway
HepG2 cells stably transfected with retroviral vector
pCFG5-IEG2 encoding a non-degradable mutant form of
IκBα, and cells with an empty vector (control) were used
to determine of the NFκB signalling pathway in IL-1-
dependent activation of mimitin gene. These cells were
kindly provided by Professor Stephan Ludwig (Heinrich-
Heine University, Duesseldorf, Germany; [24]).
For determination of MAPK signalling pathway involve-
ment in mimitin gene activation HepG2 cells were serum-
starved overnight in 0.5% FBS in DMEM. Then the cells
were pre-treated with MAPK inhibitors: 10 μM U0126
(Calbiochem), 10 μM SP600125 (Calbiochem), or 10 μM
ZM336372 (Calbiochem) for 30 min and stimulated
with15 ng/ml IL-1 for 12 h. Mimitin transcript level was
measured by real time PCR. The inhibitors' activity was
controlled by analysis of phosphorylation of MAP kinases
(Western blot). For control experiment cells were also pre-
treated with the inhibitors and stimulated with 15 ng/ml
IL-1 for 10 min. Cell lysates were analyzed by Western
blotting with anti-P-Erk and anti-P-JNK (Cell Signaling
Technology) and anti-P-p38 antibodies (Abcam).
Real Time PCR (Q-RT-PCR)
cDNA was synthesized from 1 μg of total RNA in 20 μl
using SuperScript RNaseH-  reverse transcriptase
(Promega) and oligo (dT) primer (Promega). Real time
PCR was carried out using the SYBR Green PCR Master
Mix (DyNAmo™ HS SYBR Green qPCR (Finnzyme), 1 μl
of 5× diluted cDNA, and 20 ng of each primer. For mimi-
tin transcript the forward primer was 5'-ctgcctccaccagt-
tcaaactc-3' and the reverse primer was 5'-
gtcgcatccatatacgtgaaaag-3'. The amount of each transcript,
expressed as fold-variation over control (untreated cells),
was calculated after determination of the difference
between the CT of the transcript studied and the calibrator
transcript for elongation factor 2 (EF2). The CT values used
were means of triplicate measurements.
Subcellular localization of mimitin
For subcellular fractionation of HepG2 cells the Qpro-
teome Kit (Qiagen) was used according to manufacturer's
procedure. Consecutive centrifugation and extraction
with suitable buffers allowed the isolation of cytosolic,
membrane, nuclear and cytoskeletal proteins. Protein
concentration was determined with BCA protein assay.
Additionally, the mitochondrial fraction was isolated as
described by Ndubuisi and co-workers [7]. Ten micro-
grams of protein extracts from each fraction was used in
Western blot analysis. For detection of individual proteins
different polyclonal antibodies were used (Abcam): for
the nuclear fraction – against laminin, for the cytosolic
fraction – against GAPDH, for the membrane fraction –
those against prohibitin.
ELISA
Mimitin levels in control and cytokine-stimulated HepG2
cells were measured using sandwich ELISA. A 96-well
microtiter plate was coated with rabbit polyclonal antibod-
ies against mimitin. To each well 100 μl of antibodies (6
μg/ml) diluted in 50 mM borate buffer (pH 8.35) was
added. Plates were incubated overnight at 4°C. After wash-
ing five times with PBS a protein standard (6, 12, 25, 50,
100, 200, 400, 800 pg/ml in 0.5% BSA in PBS) and cell
lysates (2.5 μg) were added in duplicates. Incubation for 1
h at 37°C was followed by washing with PBS to remove
unbound proteins. Subsequently, plates were incubated
with biotin-labelled anti-mimitin antibodies (1 μg/ml in
0.5% BSA in PBS) for 1 h at 37°C. Then, to each well 50 μl
of avidin-HRP (Sigma) (1:25000 in 0.5% BSA in PBS) was
added and incubation was carried out for 30 min at 37°C.
Each incubation step was followed by extensive washing
with PBS. The enzymatic reaction was performed using the
TMB Substrate Reagent Set (BD Biosciences), terminated by
adding 50 μl 1 M HCl and the absorbance was measured at
450 nm. The values represent the mean ± SD of three inde-
pendent experiments performed in duplicates.
siRNA transfection
Pre-designed siRNA obtained from Ambion included
GAPDH siRNA as a positive control, and siRNA with scram-
bled sequence as a negative control. The two different
siRNA sequences specific for mimitin were as follows: (A)
gaaaucaaaauaaaaagccuu and (B) gccacaaucaaugaaugcatt.
HepG2 cells were cultured in 12-well plates as described
above. The siRNA concentration and the amount of trans-
fection reagent were optimized experimentally. Before
transfection, cells were trypsinized, centrifuged at 1000BMC Cell Biology 2009, 10:23 http://www.biomedcentral.com/1471-2121/10/23
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rpm at 4°C for 5 min and resuspended in fresh medium.
Lipid-based transfection reagent siPORT NeoFX (4 μl/
well) from Ambion and siRNAs (50 nM final concentra-
tion) were separately diluted in 50 μl OPTIMEM and then
mixed together. Transfection complexes were allowed to
form for 10 min and overlayed with 9 × 104 cells per well.
As an additional control, some wells were treated with
transfection reagent only. The silencing of mimitin was
confirmed by Western blotting in three independent
experiments.
Caspase activity assay
To analyse caspase 3/7 activity, HepG2 cells were trans-
fected with mimitin-specific siRNA, GAPDH-specific
siRNA or negative control siRNA as described before. After
72 h incubation, apoptosis was induced in some of the
wells with 15 ng/ml TNFα (PromoCell) and cyclohex-
imide at the final concentration of 40 μM per well. Cells
were scraped in RIPA buffer (25 mM Tris HCl pH7.6, 150
mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1%
SDS) when most of the stimulated cells in a well showed
signs of apoptosis before complete detachment (after 5 h
of treatment). Apoptosis was assessed by analysis of acti-
vation of caspase-3 and -7 using the DVD-aminoluciferin
substrate from the Caspase-GloTM3/7 assay kit
(Promega). After protein isolation, 5 μg of protein from
each well was diluted in RIPA buffer to a final volume of
50 μl and added to an equal amount of Glo-reagent. Reac-
tion mixture was incubated for 1 h at room temperature
in the dark. Caspase 3/7 activity was measured using lumi-
nometer (MicroLumat LB96P; EG&G Berthold).
BrdU-Incorporation
HepG2 cells were transfected with siRNA specific for mim-
itin, GAPDH or negative control siRNA in a 96-well plate.
In each well 800 cells were seeded and the ratio of transfec-
tion mixture to cell density was the same as in previous
experiments. Additionally, cells were transfected in a 12-
well plate for Western blot analysis. BrdU-labelling solu-
tion from the Cell Proliferation ELISA kit (Roche Applied
Sciences) was diluted 1:2000 and added to the 96-well
plate 54 h post transfection. After 24 h of labelling, protein
fraction was isolated from 12-well plates and medium was
removed from 96-well plates. Incorporated BrdU was
detected via ELISA with anti-BrdU-POD antibody diluted
1:200 according to the manufacturer's protocol.
Yeast two-hybrid analysis
For yeast two-hybrid screening the Matchmaker human
foetal brain cDNA library was used according to manufac-
turer's procedure (Clontech). The 510-bp fragment
encoding full length cDNA of mimitin was generated by
RT-PCR using primers:
F – atgggttggtctcagga with restriction site for NdeI, and R-
atgcattcattgattgtggct with restriction site for BamHI. After
digestion with NdeI/BamHI the PCR fragment was cloned
into pGBKT7 vector of the same restriction sites. The cor-
rectness of the cDNA sequence was confirmed by sequenc-
ing. Before the cDNA library screening, two control
experiments were carried out: to verify whether the
pGBKT7-mimitin vector expresses the protein in the
AH109 strain of Saccharomyces cerevisiae, and to find out
whether the "bait" (mimitin) does not autonomously
activate the reporter genes. Expression of the fusion pro-
tein Gal4-mimitin was verified by Western blotting with
monoclonal antibodies specific for c-Myc. Two-hybrid
screening was carried out by mating the AH109 yeast
transformed with pGBKT7-mimitin (bait) and Y187 yeast
transfected with human foetal brain cDNA library in
pACT2 vector. Positive and negative controls for the
experiment were carried out in accordance with the proto-
col. A portion of the mating culture in the appropriate
dilution was plated on SD/-trp, SD/-leu and SD/-trp,-leu
selection medium to calculate the number of screened
cells and determine the mating efficiency. Altogether, we
screened 6 × 105 clones and achieved 8% mating effi-
ciency. The rest of the mating culture was spread on a plate
with SD/-trp,-leu,-his,-ade medium to select colonies con-
taining both bait and prey. Plasmids isolated from posi-
tive clones were purified from yeast and those containing
"prey" were amplified in E. coli and co-transformed to
yeast with the original bait (pGBKT7-mimitin) to verify
specific activation of the reporter genes (HIS3 and lacZ)
and the sequences compared with NCBI data.
Coimmunoprecipitation
HepG2 cells were transfected with the pcDNA3mim plas-
mid encoding mimitin or with pUHD10-3 encoding Myc-
tagged MAP1S and its transactivator pUHD15-1, or co-
transfected with all these vectors using Lipofectamine
2000 (Invitrogen). The coimmunoprecipitation analysis
was performed 24 h after transfection with the Pro-
FoundTM c-Myc Tag IP/Co-IP Kit (Pierce) following the
manufacturer's protocol. Cell lysates and obtained eluates
were loaded on 10% SDS-PAGE for Western blotting. Pro-
teins were detected with antibodies specific for mimitin
and for the Myc tag.
Statistical analysis
The data from real-time PCR, Northern blotting, measure-
ments of caspase activity and of proliferation rate were
examined for statistical significance using Student's t test.
A p value less than 0.05 was taken as statistically signifi-
cant.
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